Retinopathy of Prematurity Treatment Trends from 2003 to 2020 in the United States

Suleman I Khan; Won Yeol Ryu; Edward H Wood; Darius M Moshfeghi; Jennifer Krupa Shah; Scott R Lambert

doi:10.1016/j.ophtha.2022.06.008

Retinopathy of Prematurity Treatment Trends from 2003 to 2020 in the United States

Ophthalmology. 2022 Oct;129(10):1216-1218. doi: 10.1016/j.ophtha.2022.06.008. Epub 2022 Jun 15.

Authors

Suleman I Khan¹, Won Yeol Ryu², Edward H Wood¹, Darius M Moshfeghi¹, Jennifer Krupa Shah¹, Scott R Lambert³

Affiliations

¹ Department of Ophthalmology, Stanford University School of Medicine, Palo Alto, California.
² Department of Ophthalmology, Stanford University School of Medicine, Palo Alto, California; Department of Ophthalmology, Dong-A University College of Medicine, Busan, Republic of Korea.
³ Department of Ophthalmology, Stanford University School of Medicine, Palo Alto, California. Electronic address: lambert7@stanford.edu.

Abstract

We used population-based data obtained from Optum’s Clinformatics® Data Mart Database to characterize recent trends in retinopathy of prematurity (ROP) treatments and outcomes in the United States. Laser photocoagulation was utilized more frequently every year compared to anti-VEGF.

Publication types

Research Support, Non-U.S. Gov't
Research Support, N.I.H., Extramural

MeSH terms

Gestational Age
Humans
Infant, Low Birth Weight
Infant, Newborn
Infant, Premature
Retinopathy of Prematurity* / epidemiology
Retinopathy of Prematurity* / therapy
United States / epidemiology

Abstract

Publication types

MeSH terms

Grants and funding